Madrigal Pharmaceuticals, Inc. (MDGL) director Fred Craves, Unloaded $80,488,800 in Stock; 12 West Capital Management LP Has Trimmed Fleetcor Technologies (FLT) Stake

FleetCor Technologies, Inc. (NYSE:FLT) Logo

12 West Capital Management Lp decreased Fleetcor Technologies Inc (FLT) stake by 38.59% reported in 2018Q1 SEC filing. 12 West Capital Management Lp sold 351,475 shares as Fleetcor Technologies Inc (FLT)’s stock declined 0.90%. The 12 West Capital Management Lp holds 559,301 shares with $113.26M value, down from 910,776 last quarter. Fleetcor Technologies Inc now has $18.37 billion valuation. The stock increased 1.07% or $2.17 during the last trading session, reaching $204.98. About 416,377 shares traded. FleetCor Technologies, Inc. (NYSE:FLT) has risen 43.29% since June 13, 2017 and is uptrending. It has outperformed by 30.72% the S&P500. Some Historical FLT News: ; 03/05/2018 – Fleetcor reports unauthorized access to some of its systems; 15/05/2018 – FleetCor Presenting at JPMorgan Conference Tomorrow; 03/05/2018 – Shell Completes Fuel Card System Conversion Onto FLEETCOR Platform Across Europe and Asia; 05/04/2018 – Motus Partners with FLEETCOR to Simplify Expense Reimbursement for Mobile Workforces; 06/03/2018 Noventis And Comdata Partner To Expand Use Of Virtual Credit Cards In B2B Payments; 03/05/2018 – FLEETCOR SEES FY ADJ EPS $10.20 TO $10.50, EST. $10.30; 25/05/2018 – FLEETCOR INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of FleetCor Technologies, Inc. – FLT; 03/05/2018 – FLEETCOR and Shell Extend Fuel Card Agreement in Europe; 10/05/2018 – FLEETCOR -CO INCURRED & EXPECTS TO CONTINUE TO INCUR LEGAL & OTHER PROFESSIONAL EXPENSES RELATED TO UNAUTHORIZED ACCESS INCIDENT IN FUTURE PERIODS; 03/05/2018 – FLEETCOR TECHNOLOGIES – INVESTIGATION IS IN EARLY STAGES BUT INDICATES SIGNIFICANT NUMBER OF 6 MONTHS/OLDER GIFT CARD AND PIN NUMBERS WERE ACCESSED

More recent FleetCor Technologies, Inc. (NYSE:FLT) news were published by: which released: “Update: Lawsuit for Investors in shares of FleetCor Technologies, Inc. (NYSE: FLT) announced by Shareholders …” on May 22, 2018. Also published the news titled: “FLEETCOR INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC …” on June 09, 2018.‘s news article titled: “Kaskela Law LLC Announces Investigation of FleetCor Technologies, Inc. on Behalf of Stockholders” with publication date: June 11, 2018 was also an interesting one.

Analysts await FleetCor Technologies, Inc. (NYSE:FLT) to report earnings on August, 2. They expect $2.35 earnings per share, up 28.42% or $0.52 from last year’s $1.83 per share. FLT’s profit will be $210.65 million for 21.81 P/E if the $2.35 EPS becomes a reality. After $2.38 actual earnings per share reported by FleetCor Technologies, Inc. for the previous quarter, Wall Street now forecasts -1.26% negative EPS growth.

Investors sentiment decreased to 0.8 in Q1 2018. Its down 0.40, from 1.2 in 2017Q4. It dropped, as 39 investors sold FLT shares while 148 reduced holdings. 53 funds opened positions while 97 raised stakes. 80.19 million shares or 2.14% less from 81.94 million shares in 2017Q4 were reported. Crescent Park Lp holds 7.91% or 178,945 shares. Petrus Company Lta has 55,000 shares. Moreover, State Of Wisconsin Board has 0.06% invested in FleetCor Technologies, Inc. (NYSE:FLT) for 104,802 shares. 188,600 were accumulated by Parametric Port Associates Ltd Liability. Renaissance Techs Ltd Liability Company holds 0.03% of its portfolio in FleetCor Technologies, Inc. (NYSE:FLT) for 147,900 shares. 8,441 are held by Cambridge. State Treasurer State Of Michigan holds 4,600 shares. Rafferty Asset Mngmt Ltd Com reported 22,735 shares or 0.07% of all its holdings. Schwab Charles Inv Mngmt invested in 0.03% or 218,371 shares. Sei Invs holds 0.05% of its portfolio in FleetCor Technologies, Inc. (NYSE:FLT) for 65,473 shares. 2 are owned by Stratos Wealth Prtnrs Limited. Principal Financial Gp Incorporated Inc invested 0% in FleetCor Technologies, Inc. (NYSE:FLT). Vident Invest Advisory Lc holds 2,304 shares or 0.02% of its portfolio. Utah Retirement Systems holds 16,528 shares or 0.07% of its portfolio. United Automobile Association accumulated 150,980 shares or 0.08% of the stock.

Among 17 analysts covering Fleetcor Technologies (NYSE:FLT), 15 have Buy rating, 0 Sell and 2 Hold. Therefore 88% are positive. Fleetcor Technologies had 56 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating by Oppenheimer given on Monday, November 13. Credit Suisse initiated FleetCor Technologies, Inc. (NYSE:FLT) on Friday, December 11 with “Neutral” rating. The stock of FleetCor Technologies, Inc. (NYSE:FLT) earned “Overweight” rating by Barclays Capital on Friday, August 5. Keefe Bruyette & Woods maintained it with “Buy” rating and $221.0 target in Thursday, December 21 report. The stock has “Buy” rating by Citigroup on Thursday, November 2. Oppenheimer maintained FleetCor Technologies, Inc. (NYSE:FLT) rating on Wednesday, September 20. Oppenheimer has “Buy” rating and $185.0 target. The stock has “Outperform” rating by Keefe Bruyette & Woods on Monday, September 14. Keefe Bruyette & Woods maintained FleetCor Technologies, Inc. (NYSE:FLT) on Wednesday, February 3 with “Outperform” rating. Raymond James upgraded the stock to “Strong Buy” rating in Tuesday, May 2 report. The company was maintained on Thursday, May 25 by Jefferies.

Fred Craves, director of Madrigal Pharmaceuticals Inc is the insider, OctaFinance want to tell you about. Mr. Fred submitted a legally required report with the D.C. based-SEC informing the public of a transaction for 280,000 shares of the public firm, the one he is an insider in. At the time of the trading deal, the average stock market price per share of Madrigal Pharmaceuticals Inc was $287.5, making the stock block worth $80,488,800 U.S. Dollars. And, It’s sure Fred’s trade isn’t going to remain unnoticed as he now is owning 5.38 million shares – ( 35.28% of Madrigal Pharmaceuticals Inc’s Market Cap ).

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The company has market cap of $4.28 billion. The company's lead candidate is MGL-3196, which is in Phase II clinical trials, a liver-directed thyroid hormone receptor-ß agonist used for the treatment of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and familial hypercholesterolemia. It currently has negative earnings. It is also developing MGL-3745, which is in pre-clinical stage, a THR-ß agonist that is in preclinical trials.

The stock decreased 0.59% or $1.66 during the last trading session, reaching $281.05. About 814 shares traded. Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) has risen 630.32% since June 13, 2017 and is uptrending. It has outperformed by 617.75% the S&P500. Some Historical MDGL News: ; 08/05/2018 – MADRIGAL PHARMA 1Q REV. $0, EST. $0; 29/05/2018 – Report: Exploring Fundamental Drivers Behind Vivint Solar, Peapack-Gladstone Financial, Madrigal Pharmaceuticals, Univest Corpo; 20/04/2018 – DJ Madrigal Pharmaceuticals Inc, Inst Holders, 1Q 2018 (MDGL); 31/05/2018 – MADRIGAL PHARMACEUTICALS INC – IN PHASE 2 CLINICAL TRIAL, MGL-3196 DEMONSTRATED STATISTICAL SIGNIFICANCE IN PRIMARY ENDPOINT; 13/03/2018 – MADRIGAL PHARMACEUTICALS INC – CO IS IN A “STRONG” FINANCIAL POSITION TO ADVANCE MGL-3196 IN BOTH INDICATIONS; 31/05/2018 – MADRIGAL PHARMACEUTICALS -PHASE 2 CLINICAL TRIAL OF MGL-3196 ALSO SHOWED STATISTICALLY SIGNIFICANT RESULTS IN KEY SECONDARY ENDPOINTS

More notable recent Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) news were published by: which released: “Madrigal Pharmaceuticals Announces Proposed Public Offering of Common Stock” on June 05, 2018, also with their article: “Maxim Explains Viking Therapeutics’ Sympathy Move With Madrigal” published on June 03, 2018, published: “Madrigal Pharmaceuticals Prices Public Offering of Common Stock” on June 07, 2018. More interesting news about Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) were released by: and their article: “Pre-Open Movers 05/31: (MDGL) (VTVT) (GM) Higher; (CLSD) (CRSP) (DLTR) Lower (more..)” published on May 31, 2018 as well as‘s news article titled: “Why Viking Therapeutics Stock Is On Fire Today” with publication date: May 31, 2018.

Analysts await Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) to report earnings on August, 9. They expect $-0.60 earnings per share, up 13.04% or $0.09 from last year’s $-0.69 per share. After $-0.45 actual earnings per share reported by Madrigal Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 33.33% negative EPS growth.

FleetCor Technologies, Inc. (NYSE:FLT) Institutional Positions Chart